Fingerprint
Dive into the research topics of 'Short review of SEC, a potential dexamethasone-sparing regimen for glioblastoma: Spironolactone, ecallantide, clotrimazole'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Short review of SEC, a potential dexamethasone-sparing regimen for glioblastoma: Spironolactone, ecallantide, clotrimazole
R. E. Kast, T. C. Burns, M. E. Halatsch
Research output: Contribution to journal › Article › peer-review